Norton Rose Fulbright advises CCB International in its purchase of convertible bonds and a note issued by two Hong Kong listed companies

Business January 3, 2017

Global law firm Norton Rose Fulbright has advised CCB International on its purchase of US$9.28m and US$6.19m convertible bonds issued by Pa Shun Pharmaceutical International Holdings Limited and the US$13m note issued by Common Splendor International Health Industry Group Limited.

CCB International (Holdings) Limited is an investment services flagship, which is indirectly and wholly-owned by China Construction Bank Corporation‎.

The gross proceeds and net proceeds from the issue of the convertible bonds are US$15.5m and approximately US$14.6m, respectively. It is expected that the net proceeds will be applied to Group general working capital, business development and any future merger and acquisition transactions.

Regarding the note, the proceeds are for working capital and potential investment purposes.

The Norton Rose Fulbright team was led by Hong Kong corporate partner Terence Lau, assisted by senior associates Priscilla Lee and Sheryl Cheung. US securities partner Harold Tin was assisted by associate Tracy Ding. Hong Kong banking partner Davide Barzilai was assisted by senior associate David Milligan and associate Christine Fok.

For further information please contact:

Stuart Lennon, Senior Marketing and Communications Manager, Asia
Tel: +852 3405 2306
stuart.lennon@nortonrosefulbright.com 

Notes for editors:

Norton Rose Fulbright

Norton Rose Fulbright is a global law firm. We provide the world’s preeminent corporations and financial institutions with a full business law service. We have 3800 lawyers and other legal staff based in more than 50 cities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia.

Recognized for our industry focus, we are strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare.

Wherever we are, we operate in accordance with our global business principles of quality, unity and integrity. We aim to provide the highest possible standard of legal service in each of our offices and to maintain that level of quality at every point of contact.

For more information about Norton Rose Fulbright, see nortonrosefulbright.com/legal-notices.